Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Diclofenac is associated with a reduced incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis: results from a danish cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Modified Marshall Score Predicts Mortality in Patients With Walled-off Pancreatic Necrosis Treated in an Intensive Care Unit

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Fungal Infections in Patients With Walled-off Pancreatic Necrosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Endoscopic ultrasound-guided needle-based confocal laser endomicroscopy: a pilot study for use in focal pancreatic masses

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Secretin stimulation test for gastrin release in Zollinger-Ellison syndrome: to do or not to do?

    Research output: Contribution to journalJournal articleCommunication

  1. Large Incisional Hernias Increase in Size

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Modified Marshall Score Predicts Mortality in Patients With Walled-off Pancreatic Necrosis Treated in an Intensive Care Unit

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The cost of endoscopic treatment for walled-off pancreatic necrosis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVE: The aim of this study was to assess the clinical effect of diclofenac administered as a single dose for the prevention of postprocedure pancreatitis in a consecutive series of patients who had undergone endoscopic retrograde cholangiopancreatography (ERCP).

METHODS: Patients with a native papilla Vateri subjected to ERCP during 2010 (control group, n = 218) and 2012 (diclofenac group, n = 182) were included. Patients with a history of chronic pancreatitis or recent acute pancreatitis were excluded. From January 2012, a rectal suppository containing 100 mg of diclofenac was administered immediately after endoscopy in all patients. The primary outcome of post-ERCP pancreatitis was assessed retrospectively by reviewing the patients' charts.

RESULTS: The overall incidence of post-ERCP pancreatitis was 32 (14.7%) of the 218 patients in the control group and 9 (4.9%) of the 182 patients in the diclofenac group (P = 0.002). Moderate to severe pancreatitis occurred in 22 (10.1%) of the 218 patients in the control group versus 8 (4.4%) of the 182 patients in the diclofenac group (P = 0.036).

CONCLUSIONS: This controlled cohort study suggests that the implementation of a single dose of 100 mg of diclofenac rectally administered significantly reduces the incidence of post-ERCP pancreatitis in an unselected material of patients with native papilla.

Original languageEnglish
JournalPancreas
Volume43
Issue number8
Pages (from-to)1286-90
Number of pages5
ISSN0885-3177
DOIs
Publication statusPublished - Nov 2014

ID: 44661170